Realiza tu consulta
Recomendar a un paciente
921 13 00 04

Notamos que estás en nuestra página de España (ES). ¿Quieres cambiar de país? Elije entre las opciones:

UK
AU
Centros
Médicos
921 13 00 04
Realiza tu consulta
Recomendar a un paciente

Notamos que estás en nuestra página de España (ES). ¿Quieres cambiar de país? Elije entre las opciones:

UK
AU
Centros
Médicos
921 13 00 04
2022-12-14T10:00:00.000+11:00

Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models

Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models
Bladder Cancer, vol. 8, no. 4, pp. 339-357, 2022. DOI: 10.3233/BLC-220055.
/es/profesionales-sanitarios/estudios-e-investigacion/publicacion-de-articulos/predicting-recurrence-and-progression-in-patients-with-non-muscle-invasive-bladder-cancer-systematic-review-on-the-performance-of-risk-stratification-models
Written by Félix Guerrero-Ramos, José Daniel Subiela, Óscar Rodríguez-Faba, Julia Aumatell, Celeste Manfredi, Giorgio Bozzini, Javier Romero-Otero, Felipe Couñago
Félix Guerrero-Ramos, José Daniel Subiela, Óscar Rodríguez-Faba, Julia Aumatell, Celeste Manfredi, Giorgio Bozzini, Javier Romero-Otero, Felipe Couñago:::

 

Abstract

Several classifications have been reported to stratify non-muscle-invasive bladder cancer (NMIBC) in risk groups according to the probability of recurrence and progression.

 

Conclusion

The existing classifications show poor discrimination capability for recurrence and possibly helpful discrimination capability for progression in NMIBC patients. These results highlight the unmet need to develop novel accurate risk models for patients with NMIBC, which could be improved with the combination of clinicopathological and molecular information.

 

https://content.iospress.com/articles/bladder-cancer/blc220055